Boris Naraev
Boris G. Naraev, MD, PhD, FACP

Boris G. Naraev, MD, PhD, FACP

Dr. Naraev is a gastrointestinal medical oncologist with the Tampa General Hospital’s Cancer Institute. He has a strong clinical and research interest in pancreatic malignancies, with a particular focus on neuroendocrine tumors of the pancreas.

Prior to joining the TGH Cancer Institute, Dr. Naraev was the Lead of Neuroendocrine Cancer Program at Banner MD Anderson Cancer Center in Phoenix, Arizona, and Adjunct Assistant Professor with the Department of Gastrointestinal Medical Oncology at The University of Texas MD Anderson Cancer Center, Houston, Texas. While in Phoenix, he helped create, develop, and lead one of the largest neuroendocrine cancer programs in the Southwestern United States, and was personally taking care of a large population of patients with neuroendocrine tumors.

Later, he served as the Leader of Gastrointestinal, Neuroendocrine, and Rare Cancers Program at the Anderson Family Cancer Institute at Jupiter Medical Center in Jupiter, Florida. In this capacity, he helped build the National Pancreas Foundation Pancreatic Cancer Center of Excellence at Jupiter Medical Center.

Dr. Naraev received his Doctor of Medicine degree from Orenburg State Medical Academy in Orenburg, Russia. Subsequently, he obtained PhD in Medical Sciences degree from the same institution. After completion of Internal Medicine residency training at St. Luke’s Hospital in Chesterfield, Missouri, he proceeded to complete Hematology/Oncology Fellowship at the University of Iowa Hospitals and Clinics in Iowa City, Iowa. During his fellowship training, he developed a special interest in neuroendocrine tumors and completed several research projects in this field. Dr. Naraev is involved in research related to neuroendocrine tumors and other pancreatic and gastrointestinal cancers, community outreach, and is a member of the Guidelines Committee of the North American Neuroendocrine Tumor Society.

Share This